Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masseter myofascial pain relief with botulinum toxin type A
2019-004704-35Phase 2Completed
- Sponsor
- Region Örebro län
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myalgia comparing Botulinum toxin type A with Placebo (2 arms). Primary endpoint: Change in frequency of pain days from baseline at two months. Started Feb 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
myalgia
Beyond the preview
Go deeper on 2019-004704-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004704-35.